Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.

Seyyar M., Kalem A., Sali M., Karabuğa B., Sahin T. K., Dişli A. K., ...More

Current oncology (Toronto, Ont.), vol.33, no.6, 2026 (SCI-Expanded, Scopus)

  • Publication Type: Article / Article
  • Volume: 33 Issue: 6
  • Publication Date: 2026
  • Doi Number: 10.3390/curroncol33060365
  • Journal Name: Current oncology (Toronto, Ont.)
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, Academic Search Ultimate (EBSCO), Biomedical Reference Collection: Corporate Edition (EBSCO)
  • Recep Tayyip Erdoğan University Affiliated: Yes